StockTipsArenaBeta

BUY Anthem Biosciences Limited — Nomura India Research

BUYAnthem Biosciences Limited
Anthem Biosciences share price target & all analyst calls

byNomura India ResearchHorizon: NA (inferred 1 year)4 Nov 2026via ET Now (Live)

Entry₹862.4Inferred
Target₹900
Total upside +4.36% (call closed)
Stop lossNot given
Exit₹9005 Nov 2026, 9:16 am
Target hit+4.36%0.00%upside left
Follow Nomura India Research for new calls(100% target hit, 35 closed calls)Get alertsWatch ANTHEM for new buy/sell callsGet alertsSee 5 active Long-term calls on ANTHEMSee 542 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Nov 2026
3 supporting5 neutral1 opposing
Supports the BUY call (3)

Anthem Biosciences reported Q2 FY27 consolidated revenue of ₹5,940 million, EBITDA of ₹3,304 million, and PAT of ₹2,115 million, showing year-on-year growth in profitability and margins.

BSE · Company Update·3 Nov · yesterday

(opens in new tab)

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·19 Oct · 2w ago

Neutral / worth noting (5)

The company reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.

BSE · Board Meeting·3 Nov · yesterday

(opens in new tab)
Weighs against the BUY call (1)

Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore

NewsEt-Markets·9 Oct · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Anthem Biosciences

All analyst calls on Anthem Biosciences

More from Nomura India Research

Every call and its outcome